|
市場調査レポート
欧州におけるHIV/エイズおよびB型/C型肝炎の分子診断市場
European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
|
Abstract
This research service analyses the revenue potential for HIV/AIDS and
Hepatitis B/C molecular diagnostics markets in major western European
countries. It also gives the overview of the market in these regions together
with market drivers,restraints and challenges in the whole Europe. Together it
recommends strategies for the players in these markets to obtain best results
in the European market.
Table of Contents
1. EXECUTIVE SUMMARY
Summary of the European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
- Overview of the European HIV/AIDS and Hepatitis B/C Molecular Diagnostics
Market
2. INDUSTRY CHALLENGES
Key Industry Challenges
- Identification of Key Issues and Challenges Facing the Industry
3. MARKET ENGINEERING RESEARCH FOR THE EUROPEAN HIV/AIDS AND HEPATITIS B/C MOLECULAR DIAGNOSTICS MARKET
European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
- Market Overview
- Research Methodology
- Market Segmentation
- Market Engineering Measurements
- Market Drivers
- Market Restraints
- Revenue Model
- Revenue Forecasts
- End-user Group
- Market Trends by Geographic Region
- Technology Trends
- Product Analysis of Top Participants
- Competitive Structure
- Top Three Market Participants
European HIV/AIDS Molecular Diagnostics Market
- Overview
- Market Engineering Measurements
- Revenue Forecasts
European Hepatitis B/C Molecular Diagnostics Market
- Overview
- Market Engineering Measurements
- Revenue Forecasts
- Promising Research
4. MARKET ENGINEERING STRATEGIC RECOMMENDATIONS
Strategic Recommendations
- Strategic Recommendations for the European HIV/AIDS and Hepatitis B/C
Molecular Diagnostics Market
5. DATABASE OF KEY INDUSTRY PARTICIPANTS
Key Industry Participants in the Market
- Key Industry Participants
6. DECISION SUPPORT DATABASES
Decision Support Databases for the Industry Participants
- AIDS Incidence
- AIDS Prevalence
- AIDS Mortality
- Viral Hepatitis A Incidence
- Viral Hepatitis B Incidence
|